152 related articles for article (PubMed ID: 36815361)
1. Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Kayser S; Martínez-Cuadrón D; Rodriguez-Veiga R; Hänel M; Tormo M; Schäfer-Eckart K; Botella C; Stölzel F; Del Castillo TB; Keller U; Rodriguez-Medina C; Held G; Amigo ML; Schliemann C; Colorado M; Kaufmann M; Garcia MB; Krause SW; Görner M; Jost E; Steffen B; Zukunft S; Platzbecker U; Ho AD; Baldus CD; Serve H; Müller-Tidow C; Thiede C; Bornhäuser M; Montesinos P; Röllig C; Schlenk RF
Haematologica; 2023 Aug; 108(8):2059-2066. PubMed ID: 36815361
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Kayser S; Martínez-Cuadrón D; Hanoun M; Stölzel F; Gil C; Reinhardt HC; Aguiar E; Schäfer-Eckart K; Burgues JMB; Steffen B; Bernal T; Krause SW; Riaza R; Schliemann C; Cervera J; Kaufmann M; Torres-Miñana L; Hänel M; Acuña-Cruz E; Jost E; Algarra JL; Crysandt M; Fransecky L; Cornago-Navascues J; Kraus S; Martinez-Lopez J; Einsele H; Niemann D; Neubauer A; Seggewiß-Bernhardt R; Scholl S; Klein SA; Schmid C; Schaich M; Schmidt-Hieber M; Zukunft S; Ho AD; Platzbecker U; Baldus CD; Müller-Tidow C; Thiede C; Bornhäuser M; Serve H; Levis M; Montesinos P; Röllig C; Schlenk RF
Haematologica; 2023 Jan; 108(1):34-41. PubMed ID: 35678031
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Second Allogeneic Hematopoietic Cell Transplant in Relapsed Acute Myeloid Leukemia: Results of a Systematic Review and Meta-Analysis.
Kharfan-Dabaja MA; Reljic T; Yassine F; Nishihori T; Kumar A; Tawk MM; Keller K; Ayala E; Savani B; Mohty M; Aljurf M; Saber W
Transplant Cell Ther; 2022 Nov; 28(11):767.e1-767.e11. PubMed ID: 35970301
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality.
Liu J; Han W; Cai X; Wang Z; Cao L; Hua H; Jia Z; Chao H; Lu X; Shen H
Hematology; 2022 Dec; 27(1):565-574. PubMed ID: 35549661
[TBL] [Abstract][Full Text] [Related]
5. Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT.
Chevallier P; Labopin M; Nagler A; Ljungman P; Verdonck LF; Volin L; Zander AR; Finke J; Socie G; Cordonnier C; Harousseau JL; Mohty M; Rocha V;
Bone Marrow Transplant; 2009 Nov; 44(9):589-94. PubMed ID: 19349953
[TBL] [Abstract][Full Text] [Related]
6. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8.
Konuma T; Kondo T; Yamashita T; Uchida N; Fukuda T; Ozawa Y; Ohashi K; Ogawa H; Kato C; Takahashi S; Kanamori H; Eto T; Nakaseko C; Kohno A; Ichinohe T; Atsuta Y; Takami A; Yano S;
Ann Hematol; 2017 Mar; 96(3):469-478. PubMed ID: 28058493
[TBL] [Abstract][Full Text] [Related]
7. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
[TBL] [Abstract][Full Text] [Related]
8. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Konuma T; Mizuno S; Kondo T; Yamaguchi H; Fukuda T; Uchida N; Najima Y; Kanamori H; Ota S; Nakamae H; Nakamae M; Mizuno I; Sugita J; Onishi Y; Yokota A; Takahashi S; Kanda Y; Ichinohe T; Atsuta Y; Yano S;
Ann Hematol; 2018 Nov; 97(11):2173-2183. PubMed ID: 29978286
[TBL] [Abstract][Full Text] [Related]
10. Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT.
Baron F; Labopin M; Blaise D; Itälä-Remes M; Socié G; Forcade E; Yakoub-Agha I; Gorin NC; Esteve J; Nagler A; Mohty M
Bone Marrow Transplant; 2021 Feb; 56(2):461-469. PubMed ID: 32887941
[TBL] [Abstract][Full Text] [Related]
11. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
[No Abstract] [Full Text] [Related]
12. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
[TBL] [Abstract][Full Text] [Related]
13. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
14. Analysis of relapse after transplantation in acute leukemia: A comparative on second allogeneic hematopoietic cell transplantation and donor lymphocyte infusions.
Ortí G; Sanz J; García-Cadenas I; Sánchez-Ortega I; Alonso L; Jiménez MJ; Sisinni L; Azqueta C; Salamero O; Badell I; Ferra C; de Heredia CD; Parody R; Sanz MA; Sierra J; Piñana JL; Querol S; Valcárcel D
Exp Hematol; 2018 Jun; 62():24-32. PubMed ID: 29526774
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
Walter RB; Gooley TA; Wood BL; Milano F; Fang M; Sorror ML; Estey EH; Salter AI; Lansverk E; Chien JW; Gopal AK; Appelbaum FR; Pagel JM
J Clin Oncol; 2011 Mar; 29(9):1190-7. PubMed ID: 21282535
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Kayser S; Kramer M; Martínez-Cuadrón D; Grenet J; Metzeler KH; Sustkova Z; Luskin MR; Brunner AM; Elliott MA; Gil C; Marini SC; Ráčil Z; Cetkovsky P; Novak J; Perl AE; Platzbecker U; Stölzel F; Ho AD; Thiede C; Stone RM; Röllig C; Montesinos P; Schlenk RF; Levis MJ
Haematologica; 2022 Apr; 107(4):836-843. PubMed ID: 34348451
[TBL] [Abstract][Full Text] [Related]
18. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Farag SS; Archer KJ; Mrózek K; Vardiman JW; Carroll AJ; Pettenati MJ; Moore JO; Kolitz JE; Mayer RJ; Stone RM; Larson RA; Bloomfield CD
Int J Oncol; 2002 Nov; 21(5):1041-51. PubMed ID: 12370753
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.
Visani G; Bernasconi P; Boni M; Castoldi GL; Ciolli S; Clavio M; Cox MC; Cuneo A; Del Poeta G; Dini D; Falzetti D; Fanin R; Gobbi M; Isidori A; Leoni F; Liso V; Malagola M; Martinelli G; Mecucci C; Piccaluga PP; Petti MC; Rondelli R; Russo D; Sessarego M; Specchia G; Testoni N; Torelli G; Mandelli F; Tura S
Leukemia; 2001 Jun; 15(6):903-9. PubMed ID: 11417475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
